Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 1
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction.
Rabaan AA, AlSaihati H, Bukhamsin R, Bakhrebah MA, Nassar MS, Alsaleh AA, Alhashem YN, Bukhamseen AY, Al-Ruhimy K, Alotaibi M, Alsubki RA, Alahmed HE, Al-Abdulhadi S, Alhashem FA, Alqatari AA, Alsayyah A, Farahat RA, Abdulal RH, Al-Ahmed AH, Imran M, Mohapatra RK. Rabaan AA, et al. Among authors: alsaihati h. Curr Oncol. 2023 Feb 6;30(2):1954-1976. doi: 10.3390/curroncol30020152. Curr Oncol. 2023. PMID: 36826113 Free PMC article. Review.
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics.
Rabaan AA, Bukhamsin R, AlSaihati H, Alshamrani SA, AlSihati J, Al-Afghani HM, Alsubki RA, Abuzaid AA, Al-Abdulhadi S, Aldawood Y, Alsaleh AA, Alhashem YN, Almatouq JA, Emran TB, Al-Ahmed SH, Nainu F, Mohapatra RK. Rabaan AA, et al. Among authors: alsaihati h. Molecules. 2022 Dec 7;27(24):8659. doi: 10.3390/molecules27248659. Molecules. 2022. PMID: 36557793 Free PMC article. Review.
Artificial Intelligence for Clinical Diagnosis and Treatment of Prostate Cancer.
Rabaan AA, Bakhrebah MA, AlSaihati H, Alhumaid S, Alsubki RA, Turkistani SA, Al-Abdulhadi S, Aldawood Y, Alsaleh AA, Alhashem YN, Almatouq JA, Alqatari AA, Alahmed HE, Sharbini DA, Alahmadi AF, Alsalman F, Alsayyah A, Mutair AA. Rabaan AA, et al. Among authors: alsaihati h. Cancers (Basel). 2022 Nov 14;14(22):5595. doi: 10.3390/cancers14225595. Cancers (Basel). 2022. PMID: 36428686 Free PMC article. Review.
Protein kinase C inhibitors override ZEB1-induced chemoresistance in HCC.
Sreekumar R, Emaduddin M, Al-Saihati H, Moutasim K, Chan J, Spampinato M, Bhome R, Yuen HM, Mescoli C, Vitale A, Cillo U, Rugge M, Primrose J, Hilal MA, Thirdborough S, Tulchinsky E, Thomas G, Mirnezami A, Sayan AE. Sreekumar R, et al. Cell Death Dis. 2019 Sep 23;10(10):703. doi: 10.1038/s41419-019-1885-6. Cell Death Dis. 2019. PMID: 31543517 Free PMC article.
The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer.
Sreekumar R, Al-Saihati H, Emaduddin M, Moutasim K, Mellone M, Patel A, Kilic S, Cetin M, Erdemir S, Navio MS, Lopez MA, Curtis N, Yagci T, Primrose JN, Price BD, Berx G, Thomas GJ, Tulchinsky E, Mirnezami A, Sayan AE. Sreekumar R, et al. Mol Oncol. 2021 Aug;15(8):2065-2083. doi: 10.1002/1878-0261.12965. Epub 2021 May 1. Mol Oncol. 2021. PMID: 33931939 Free PMC article.